Phase I Study of Paclitaxel in Combination With a Multidrug Resistance Modulator, PSC 833 (Valspodar), in Refractory Malignancies ABSTRACT: Tumor progression is a complex, multistage process by which ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results